Safety and Efficacy Study of Autologous Bone Marrow Aspirate Concentrate for No-Option Critical Limb Ischemia

NCT01818310 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Critical Lower Limb Ischemia
Type-2 Diabetes Mellitus

Interventions

BIOLOGICAL: Group A: Intramuscular
BIOLOGICAL: Group B: Intraarterial
BIOLOGICAL: Group C: Intravenous
PROCEDURE: Group D: Surgical endovascular treatment with maximum medicamentous treatment

Sponsor

University Hospital Ostrava

Collaborators

[object Object]
[object Object]